Creating a future of personalized medicine: U-M forms
nonprofit joint venture for advanced DNA diagnostics
Paradigm, formed in partnership with International Genomics
Consortium, will help doctors tailor treatment
As a key step toward providing patients with treatments
based on their own DNA profiles, the University of Michigan and the
International Genomics Consortium (IGC) have launched a new joint venture that
will help usher in an age of personalized medicine.
Called Paradigm, the new nonprofit company brings together
the expertise of the U-M Health System and IGC, two leaders in using genetic
information to understand and treat disease.